Gynuity Health Projects


Resources by Topic

Medical Abortion (View all)

Misoprostol for Early Abortion

Map of Mifepristone Approvals

List of Mifepristone Approvals

Medical Abortion Guidebook

Mifepristone medical abortion in Albania

Regimens of misoprostol with mifepristone for early medical abortion

Use of sequential serum hCG and sonography for medical abortion only when indicated

Are two doses of misoprostol after mifepristone for early abortion better than one?

Alternatives to mifepristone for early medical abortion

Mifepristone for late first trimester abortion

Can mifepristone medical abortion be simplified?

Methotrexate compared to misoprostol alone for early medical abortion

Assessment of pregnancy duration among termination of pregnancy clients in South Africa

Medical Abortion Program Brief

Choices for Medical Abortion Introduction in Brazil, Colombia, Mexico and Peru

Supervision for use of mifepristone medical abortion

Integrating medical abortion into safe abortion services in South Africa

Expanding Choice in Abortion Services in Armenia

Two distinct oral routes of misoprostol in mifepristone medical abortion

Sublingual misoprostol after mifepristone

Non-physician clinicians can safely provide first trimester medical abortion

Oral vs. sublingual misoprostol (400 mcg) following 200 mg mifepristone

Increasing women’s choices in medical abortion in Turkey

Knowledge, attitudes, and practice of abortion among women and doctors in Armenia

Acceptability and feasibility of medical abortion in Nepal

Alternatives to Routine Follow-Up for Early Medical Abortion

Home administration of misoprostol for early medical abortion in India

ICMA Third International Conference

Medical abortion: Outcomes in a family medicine setting

Abortion With Self-Administered Misoprostol: A Guide For Women

Buccal vs. sublingual misoprostol after mifepristone for medical abortion

Alternatives to routine ultrasound for eligibility assessment prior to medical abortion

Introduction and provision of medical abortion: A tale of two countries

Medical abortion for adolescents

Comparing two early medical abortion regimens: Mifepristone+misoprostol vs. misoprostol alone

Review of the Literature on Patient Satisfaction with Early Medical Abortion

Mifepristone and Misoprostol Compared With Misoprostol Alone for Second-trimester Abortion

Comparison of regimens for home-based early medical abortion in Tunisia and Vietnam

Two doses of buccal misoprostol following mifepristone

Use of Medicines Changing the Face of Abortion

Clinic-level introduction of medical abortion in Vietnam

Outpatient medical abortion through 70 days

At-home semi-quantitative pregnancy tests as replacement for clinical follow-up of medical abortion

Armenia: A Way to Make Abortion Safer

First-trimester medical abortion with mifepristone 200 mg and misoprostol: A systematic review

Mifepristone-Misoprostol for early Medical Abortion in Uzbekistan

Efficacy and acceptability of early mifepristone-misoprostol medical abortion in Ukraine

Simplified medical abortion using a semi-quantitative pregnancy test for home-based follow-up

Acceptability and Feasibility of Mifepristone-Misoprostol For Menstrual Regulation in Bangladesh

Prophylactic compared with therapeutic Ibuprofen analgesia in first-trimester medical abortion

Acceptability of home use of mifepristone for medical abortion

Medical abortion: A path to safe, high-quality abortion care in Latin America and the Caribbean

A two-pill sublingual misoprostol outpatient regimen following mife for MA through 70 days’ LMP

Acceptability and feasibility of phone follow-up after early medical abortion in Vietnam

Mife plus miso or miso-alone for abortion induction in pregnancies 12-24 weeks’ LMP

FAQ on Misoprostol Detection in Blood

Acceptability and feasibility of medical abortion with mifepristone and misoprostol in Nigeria

Medical abortion work in Eastern Europe/Central Asia

Efficacy and acceptability of a mifepristone-misoprostol combined regimen for early induced abortion

Acceptability and feasibility of mifepristone medical abortion in the early first trimester in Azerb

Claims of misoprostol use based on blood sampling should be viewed with skepticism

What happens when we routinely give doxycycline to medical abortion patients?

Knowledge of Abortion Laws and Services among Low-Income Women in Three United States Cities

The introduction of first trimester medical abortion in Armenia

Phone follow-up with SQPT after medical abortion in Moldova and Uzbekistan

Safety, efficacy and acceptability of outpatient mifepristone-misoprostol MA through 70 days

A prospective open-label study of home use of mifepristone for medical abortion in Nepal

Early Medical Abortion without Prior Ultrasound

Off-label indications for mifepristone in gynecology and obstetrics

Reaching women where they are

Outpatient medical abortion is safe and effective through 70 days gestation

A double-blind randomized controlled trial of mifepristone or placebo before buccal misoprostol

Fifteen years: looking back and looking forward

Is It Safe to Provide Abortion Pills Over The Counter?

A prospective, non-randomized study of home-use of mifepristone for medical abortion in the U.S.

Home use of urine pregnancy tests for medical abortion follow-up

Cervical Preparation Before Dilation and Evacuation Using Adjunctive Misoprostol or Mifepristone

Continuing pregnancy after mifepristone and “reversal” of first-trimester medical abortion

If we can do it for misoprostol, why not for mifepristone?

Mifepristone label laws and trends in use: recent experiences in four US states

Effect of Immediate Compared with Delayed Insertion of Etonogestrel Implants

Medical abortion

Innovative research at the 2016 National Abortion Federation Annual Meeting

Self-administered multi-level pregnancy tests in simplified follow-up of medical abortion in Tunisia

Determining early medical abortion outcomes at 3, 7 and 14 days after mifepristone

Home use of mifepristone and misoprostol for MA up to 10weeks of pregnancy in Kazakhstan

Prospective study of home use of mifepristone and misoprostol for medical abortion up to 10weeks

Effects of Depot Medroxyprogesterone Acetate Injection Timing on MA Efficacy and Repeat Pregnancy

Acceptability & feasibility of 400μg buccal misoprostol after 200 mg mife for early MA in Georgia

Two prophylactic medication approaches in addition to a pain control regimen for early MA

Simultaneous Administration Compared With a 24-Hour Mifepristone-Misoprostol Interval

Second trimester MA with mifepristone followed by unlimited dosing of buccal misoprostol in Armenia

800μg misoprostol and mucosal and systemic immune activation or the cervicovaginal microbiome

Serial Multilevel Urine Pregnancy Testing to Assess Medical Abortion Outcome

Dissemination and implementing a core outcome set for medical and surgical abortion

Abortion choices among women in Cambodia after introduction of a marketed medicated abortion product

Sixteen Years of Overregulation: Time to Unburden Mifeprex

FAQs on the Use of Multi-level Pregnancy Tests for Medical Abortion

Results of a pilot study in the U.S. and Vietnam to assess the utility and acceptability of a MLPT

Study finds that obtaining abortion pills from the internet is feasible in the US